Airway Resistome Higher In Chronic Lung Disease
Recent antibiotic exposure was linked to greater antimicrobial resistance gene burden in bronchoscopy samples of patients with chronic lung disease.
By
Andrea Surnit
March 27, 2026
Clinical Scorecard: Airway Resistome Higher In Chronic Lung Disease
At a Glance
Category Detail
Condition Chronic Lung Disease Key Mechanisms Higher prevalence of antimicrobial resistance genes in lower airway microbiome. Target Population Patients with chronic lung diseases such as sarcoidosis, idiopathic pulmonary fibrosis, and COPD. Care Setting Clinical research setting involving bronchoscopy and metagenomic sequencing.
Key Highlights
Patients with sarcoidosis and IPF showed the highest odds of harboring antimicrobial resistance genes. Tetracycline resistance genes were found in 33% of samples, with higher prevalence in chronic lung disease patients. Recent antibiotic exposure significantly increased the burden of resistance genes. Guideline-Based Recommendations
Diagnosis
Utilize bronchoscopy with sterile sampling for accurate assessment of airway resistome. Management
Monitor antibiotic use and its impact on resistance gene prevalence in chronic lung disease patients. Monitoring & Follow-up
Regular assessment of lung function and resistance gene counts in patients with chronic lung diseases. Risks
Increased risk of antimicrobial resistance in patients with sarcoidosis and IPF. Patient & Prescribing Data
Patients with chronic lung diseases, particularly those with a history of exacerbations.
Antibiotic exposure within 3 months correlates with higher resistance gene counts.
Clinical Best Practices
Avoid unnecessary antibiotic prescriptions in chronic lung disease patients. Educate patients on the risks of antibiotic use and resistance. Related Resources & Content
